Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered

Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered — Trials · CancerIndex

Clinical trials

Registered studies

8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 0
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: —
Top sponsor: —
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00946335	ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors	completed	Phase 1	31	National Cancer Institute (NCI)NIH	1	Jul 9, 2014	clinicaltrials
NCT00052780	Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors	completed	Phase 1	72	National Cancer Institute (NCI)NIH	1	Sep 30, 2013	clinicaltrials